🚀 IPO Center
The full arc of a listing in one place: the mega-IPO pipeline while it's still private, the calendar and debut performance when it lists, and the flow events — lockup expiries, greenshoe windows, index fast-entry dates — that actually move new listings afterward.
🎯 IPO Center — Live Tracker
⚡ Starter+
live
Every new listing on one board — the live QuantLogix 5-factor signal, debut return vs. offer, and the next flow event that moves it (lockup, greenshoe, index fast-entry). ⭐ a name to track it and get alerted on any headline.
Mega-IPO Watch
🚀 Graduated: SpaceX listed June 12, 2026 in the largest IPO on record — its flow events are tracked below. Read the allocator's debut analysis →
IPO Pipeline — S-1 Watch
Every tracked pre-IPO company, tiered by how real the listing is: registration statements actually on file, listings the company has signaled, and the biggest names the market keeps pricing a debut into.
S-1 FILEDregistration statement on file — a listing can price from here EXPECTEDcompany or bankers have signaled a listing BIGGEST RUMOREDlargest private valuations with recurring IPO chatter
December 9, 2026in 141d
SpaceX
Lockup expiry (est.) est.
Standard 180-day lockup convention — confirm exact terms in the final prospectus. First window for pre-IPO holders (insiders, early funds) to sell.
Upcoming IPOs
TickerCompanyExpectedPriceSize
REF
Reformation Inc.
TBA
$15–$17
$239Mpreview →
GENN
Genneia S.A.
TBA
—
preview →
NUOX
NuvOx Therapeutics Inc.
TBA
$8
$23Mpreview →
BLSM
BlossomHill Therapeutics Inc..
TBA
—
$100Mpreview →
LTGO
Latigo Biotherapeutics Inc.
TBA
—
$100Mpreview →
JMKE
Jersey Mikes Subs Inc.
TBA
$21–$25
$1.1Bpreview →
CUX
CopperTech Metals Inc
TBA
$16–$18
$424Mpreview →
TARX
Tarsier Pharma Ltd.
TBA
$8–$10
$56Mpreview →
MOT
MetaOptics Ltd.
TBA
$5–$7
$21Mpreview →
EMI
Encore Medical Inc.
TBA
$5
$15Mpreview →
VOGX
Vogenx Inc.
TBA
—
$75Mpreview →
BRVE
Braveheart Bio Inc.
TBA
—
$100Mpreview →
CSCM
Crestone Strategic Capital Acquisition Corp.
TBA
$10
$75Mpreview →
YLUZ
YPF Electric Energy S.A.
TBA
—
preview →
IMC
IMC Rare Earths Ltd.
TBA
$4–$6
$32Mpreview →
ATTO
Attovia Therapeutics Inc.
TBA
—
$100Mpreview →
STA
Starton Holdings Inc
TBA
$5–$7
$35Mpreview →
ININ
Sin Lian Seng Construction
TBA
$4
$25Mpreview →
APMD
Apnimed Inc.
TBA
—
$100Mpreview →
MENW
Tailored Brands Inc.
TBA
—
$100Mpreview →
Recent Debuts — graded vs offer price
TickerCompanyListedIPO $NowSince IPO
STDN
Standard Nuclear Inc.
July 16, 2026
$15
$9.02
-39.9%signal →
CSQR
Csquare Inc.
July 16, 2026
$21
$20.00
-4.8%signal →
RACD
Research Alliance Corp. IV
July 13, 2026
$10
$10.36
+3.6%signal →
SKHY
SK Hynix Inc
July 10, 2026
$158.14
$151.16
-4.4%signal →
ITG
ITG Inc.
July 1, 2026
$16
$11.40
-28.7%signal →
BSP
Bending Spoons S.p.A.
July 1, 2026
$29
$33.42
+15.2%signal →
LIME
Neutron Holdings Inc.
July 1, 2026
$25
$25.02
+0.1%signal →
SIND
Sinda Ltd.
June 26, 2026
$12
$12.43
+3.6%signal →
DSC
DSC Holdings Ltd.
June 25, 2026
$17
$5.60
-67.1%signal →
DPC
DPC Holdings PLC
June 25, 2026
$33
$45.06
+36.5%signal →
FCBM
First Carolina Financial Services Inc
June 18, 2026
$12.5
$12.80
+2.4%signal →
KARD
Kardigan Inc.
June 18, 2026
$16
$21.40
+33.7%signal →
📈 IPO Performance Leaderboard + QL Signal
Recent debuts ranked by return since their offer price, each carrying the live QuantLogix 5-factor signal — so you can see which IPOs the engine actually rates a Buy today, not just which popped on day one. Refreshed weekly.
AVLN +57.2% best since IPO
DSC -71.7% worst
-0.2% avg return
8 QL-rated Buy
1 QL-rated Sell
#TickerCompanyIPO $NowSince IPOQL Signal
1
AVLN
Avalyn Pharma Inc.
$18
$28.30
+57.2%
Buy 58
2
PBLS
Parabilis Medicines Inc.
$20
$29.55
+47.8%
Buy 59
3
DPC
DPC Holdings PLC
$33
$46.27
+40.2%
Neutral 55
4
NHP
National Healthcare Properties Inc.
$12
$15.86
+32.2%
Strong Buy 76
5
KARD
Kardigan Inc.
$16
$21.13
+32.1%
Neutral 51
6
SPTX
Seaport Therapeutics Inc.
$18
$20.85
+15.8%
Buy 61
7
SIND
Sinda Ltd.
$12
$13.63
+13.6%
Buy 61
8
BSP
Bending Spoons S.p.A.
$29
$32.40
+11.7%
Neutral 51
9
LCLN
Lincoln International Inc.
$20
$22.02
+10.1%
Neutral 48
10
FRBT
Forbright Inc.
$18
$19.05
+5.8%
Neutral 52
11
LIME
Neutron Holdings Inc.
$25
$26.21
+4.8%
Neutral 48
12
RACD
Research Alliance Corp. IV
$10
$10.40
+4.0%
Strong Buy 68
13
FCBM
First Carolina Financial Services Inc
$12.5
$12.85
+2.8%
Neutral 57
14
INIO
Innio N.V.
$27
$27.72
+2.7%
Neutral 57
15
AMAN
Amanat Acquisition Corp
$10
$10.10
+1.0%
Neutral 53
Deep-Dive IPO Briefs
Long-form pre-IPO research on the pipeline's biggest names — financials, valuation math, listing mechanics, and the bear case.
How IPO flow events work
What is an IPO lockup expiry?
A lockup bars pre-IPO holders (insiders, employees, early funds) from selling for a set period after listing — typically 180 days. The expiry date is a scheduled supply event: a large block of shares becomes sellable at once, which is why new listings often trade weakly into and around the date.
What is a greenshoe option?
An over-allotment option letting underwriters sell up to ~15% additional shares and stabilize the price for about 30 days after listing. While the window is open, the underwriters are a price-supporting presence; once it closes, that support ends.
What is index fast entry and why does it move IPO stocks?
Index providers can admit very large new listings on an accelerated schedule — FTSE Russell can add a qualifying IPO to the Russell 1000/3000 after five trading days, and Nasdaq can admit one to the Nasdaq-100 after fifteen. Entry forces every index-tracking fund to buy, creating scheduled, mandatory demand with a date on it.
Should I buy an IPO on the first day?
Academic IPO research (notably Jay Ritter’s long-run dataset) finds first-day buyers systematically overpay: the average IPO pops on day one, then underperforms over the following years. Allocators instead trade the flow calendar — index-entry dates, greenshoe close, the first earnings prints, and the lockup expiry. QuantLogix is a research platform; this is educational context, not advice.